In a murine model of polymicrobial sepsis, the exogenous administration of an anticoagulant antibody that selectively blocks FXI activation by FXII led to reduced IL-6 and TNF-a, reduced PLT consumption, and improved overall survival [26]. This evidence concerns the gene TNF and Sepsis.